Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Charalambos Kouroussis"'
Autor:
Drakoulis Yannoukakos, Despoina Kalfakakou, Nikolaos Androulakis, Paraskevi Apostolou, Sofia Agelaki, Elias Sanidas, Antonia Kalykaki, Christos Papadimitriou, Vassilis Georgoulias, Konstantinos Kalbakis, Lambros Vamvakas, Christos Christodoulou, Charalambos Kouroussis, Dimitris Mavroudis, Florentia Fostira, Irene Konstantopoulou, Angeliki Delimitsou, Emmanouil Saloustros
Publikováno v:
International Journal of Cancer. 147:1334-1342
Germline BRCA1 and BRCA2 loss-of-function variants have been linked to increased breast and ovarian cancer risk, with more than 5,000 distinct pathogenic variants being reported worldwide. Among individuals of Greek descent, the BRCA1/2 variant spect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc65d4db478ffe4347c7e147a3269b24
https://doi.org/10.1002/ijc.32903
https://doi.org/10.1002/ijc.32903
Autor:
Kostas Kalbakis, Dora Hatzidaki, Vassilis Georgoulias, Nikolaos Vardakis, Aris Polyzos, Nikolaos Kentepozidis, Athanasios Kotsakis, John Syrios, Charalambos Kouroussis, Emmanouil Kontopodis
Publikováno v:
Minerva ginecologica. 71(3)
Background Evaluation of safety of the weekly intravenous gemcitabine/topotecan combination as salvage treatment in patients with recurrent epithelial ovarian cancer. Methods Twenty-four women with histologically-proven relapsed ovarian cancer (ROC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e67dcddfcf87a424099cc6c438df32
https://pubmed.ncbi.nlm.nih.gov/30727721
https://pubmed.ncbi.nlm.nih.gov/30727721
Autor:
Michael Vaslamatzis, P. Makrantonakis, Athanasios Athanasiadis, Athina Christopoulou, Charalampos Christofyllakis, Christos Emmanouilides, Iliada Bompolaki, Ioannis Sougklakos, Stylianos Kakolyris, Nikolaos Ziras, Efthimios Prinarakis, Nikolaos K. Kentepozidis, Ageliki Kalisperi, Spyros Xynogalos, Ioannis Boukovinas, Alexandros Ardavanis, Charalambos Kouroussis, Nikolaos Androulakis, Dimitrios Mavroudis, Vassilis Georgoulias
Publikováno v:
Journal of Clinical Oncology. 37:3500-3500
3500 Background: The IDEA aimed to investigate whether a 3-month (3M) of oxaliplatin/fluoropyrimidines-based adjuvant chemotherapy (CT) is non-inferior to the 6-month (6M) in 3-year disease free survival (DFS) in stage high risk stage II and in stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b70de71478db5f12f5feaf5cf173f1b
https://doi.org/10.1200/jco.2019.37.15_suppl.3500
https://doi.org/10.1200/jco.2019.37.15_suppl.3500
Autor:
Vassilis Georgoulias, Athanasios Karampeazis, P. Makrantonakis, Michael Vaslamatzis, Nikolaos Ziras, Athanasios Anagnostopoulos, Charalambos Kouroussis, Anna Koumarianou, Nikolaos K. Kentepozidis, Aristidis Polyzos, Christos Emmanouilides, Athanasios Athanasiadis, Stylianos Kakolyris, Ilias Athanasiadis, Ioannis Boukovinas, Dora Hatzidaki, Athina Christopoulou, Spyros Xynogalos, Efthimios Prinarakis
Publikováno v:
Journal of Clinical Oncology. 36:e15521-e15521
e15521Background: Bevacizumab (BEV) is an active antiangiogenic agent for the treatment of all patients (pts) with advanced colorectal cancer (CRC). We investigated the toxicity, compliance and sur...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e568b18bfe047094d43570982338dc0b
https://doi.org/10.1200/jco.2018.36.15_suppl.e15521
https://doi.org/10.1200/jco.2018.36.15_suppl.e15521
Autor:
Nikolaos Karvounis, Aristides Polyzos, Kostas N. Syrigos, Kostas Kalbakis, Nikolaos Ziras, P. Papakotoulas, Athanasios Athanasiadis, Vassilis Georgoulias, Adamos Adamou, Stylianos Kakolyris, Dimitris Mavroudis, Charalambos Kouroussis, Charalambos Christophyllakis, Nikolaos Malamos, Lambros Vamvakas, Ioannis Varthalitis, Ioannis Boukovinas
Publikováno v:
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2009, 119 (1), pp.95-104. ⟨10.1007/s10549-009-0468-0⟩
Breast Cancer Research and Treatment, Springer Verlag, 2009, 119 (1), pp.95-104. ⟨10.1007/s10549-009-0468-0⟩
International audience; A randomized multicenter phase III study was conducted to compare the sequential docetaxel followed by epirubicin/cyclophosphamide combination with that of FEC regimen as adjuvant chemotherapy in women with axillary node-posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd98f938cb559c5cdada0bf703f1933
https://doi.org/10.1007/s10549-009-0468-0
https://doi.org/10.1007/s10549-009-0468-0
Autor:
Kostas Kalbakis, Athanasios Kotsakis, Vassilis Georgoulias, Nikolaos Vardakis, Antonia Kalykaki, Stelios Giassas, Zacharenia Saridaki, Charalambos Kouroussis, Lambros Vamvakas, Nikolaos Kentepozidis
Publikováno v:
Oncology. 76:112-117
Purpose: Temozolomide, a novel triazene derivative, has shown activity in vitro against lung cancer as well as against brain metastases from a variety of solid tumors including non-small cell lung cancer (NSCLC). The aim of the study was to evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d74df7fb331f86b4369e1e97d3e7ae82
https://doi.org/10.1159/000192586
https://doi.org/10.1159/000192586
Autor:
Evi Lianidou, Stella Apostolaki, Irene Bolonaki, M. Perraki, Vassilis Georgoulias, Katerina Argyraki, Charalambos Kouroussis, N. Xenidis, Maria Kafousi, Charalambos Christophylakis, Thanos Pallis, Kostas Kalbakis, Stathis Stathopoulos, Aliki Stathopoulou, Dimitris Mavroudis, Nikos Androulakis
Publikováno v:
Journal of Clinical Oncology. 24:3756-3762
Purpose To evaluate the predictive and prognostic value of peripheral blood cytokeratin-19 (CK-19) mRNA-positive cells in axillary lymph node–negative breast cancer patients. Patients and Methods Peripheral blood was obtained from 167 node-negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f175c510325d546ec362b5cb0ed89ec5
https://doi.org/10.1200/jco.2005.04.5948
https://doi.org/10.1200/jco.2005.04.5948
Autor:
V. Georgoulias, A. Argyraki, A. Geroyianni, C.-H. Christophylakis, N. Karvounis, S. Kakolyris, A. Agelidou, Charalambos Kouroussis, E. Tsaroucha, M. Agelidou, M. Veslemes, Nikos Androulakis
Publikováno v:
Lung Cancer. 53:59-65
Summary Purpose To evaluate the efficacy and tolerance of a cisplatin plus etoposide regimen followed by thoracic radiotherapy (TRT) and paclitaxel plus cisplatin consolidation chemotherapy in patients with limited stage small cell lung cancer (SCLC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60971d6395abe38f95d1dc109e8d0ffe
https://doi.org/10.1016/j.lungcan.2006.03.011
https://doi.org/10.1016/j.lungcan.2006.03.011
Autor:
Sophia Agelaki, Charalambos Kouroussis, Nikolaos Malamos, Vassilis Georgoulias, Dimitris Mavroudis, Alexandros Ardavanis, Kostas N. Syrigos, Kostas Kalbakis, Lambros Vamvakas, Nikolaos Kentepozidis, Athanasios Kotsakis
Publikováno v:
Cancer Chemotherapy and Pharmacology. 58:742-748
Purpose: To investigate the activity and tolerance of pegylated liposomal doxorubicin in combination with vinorelbine in pretreated patients with metastatic breast cancer. Patients and treatment: Thirty-six women with metastatic breast cancer were en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa53c91e8a6ce2b2ae637dbb05f17854
https://doi.org/10.1007/s00280-006-0236-3
https://doi.org/10.1007/s00280-006-0236-3
Autor:
Aristidis Polyzos, C. Christodoulou, Charalambos Kouroussis, George Fountzilas, Helen Gogas, E. Linardou, H. P. Kalofonos, E. Briassoulis, T. G. Iconomou, S. Chalkidou, Dimitris Bafaloukos, P. Panagiotou, Eleni Efstathiou, Dimosthenis Tsoutsos
Publikováno v:
Annals of Oncology. 16:950-957
Purpose: Temozolomide (TMZ) is an oral alkylating agent that produces methyl adducts at the 0.6 position of guanine. The methyl adducts are removed by the DNA repair enzyme AGAT. As demonstrated by in vitro studies, cisplatin (CDDP) is able to down-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0bc60e4cfe42cf15e1227809968911
https://doi.org/10.1093/annonc/mdi190
https://doi.org/10.1093/annonc/mdi190